Identifying the Local Emergence of Medetomidine Through Prehospital Collaborations

Medetomidine, an emerging adulterant, further complicates the clinical care of exposed patients in overdose and magnifies features of xylazine exposure. In this case, prehospital data and clinical observation led to the identification of medetomidine in our community. With appropriate analytical toxicology resources, pre-hospital providers can translate clinical observation into new drug or adulterant identification, improving clinical care and public health.